Literature DB >> 20819887

Licensing drugs for diabetes.

Richard Lehman, John S Yudkin, Harlan Krumholz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819887     DOI: 10.1136/bmj.c4805

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Rosiglitazone: a European regulatory perspective.

Authors:  E Blind; K Dunder; P A de Graeff; E Abadie
Journal:  Diabetologia       Date:  2010-12-14       Impact factor: 10.122

2.  Understanding drug preferences, different perspectives.

Authors:  Peter G M Mol; Arna H Arnardottir; Sabine M J Straus; Pieter A de Graeff; Flora M Haaijer-Ruskamp; Elise H Quik; Paul F M Krabbe; Petra Denig
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 3.  General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis.

Authors:  Lasse T Krogsbøll; Karsten Juhl Jørgensen; Christian Grønhøj Larsen; Peter C Gøtzsche
Journal:  BMJ       Date:  2012-11-20

4.  General health checks in adults for reducing morbidity and mortality from disease.

Authors:  Lasse T Krogsbøll; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2019-01-31

Review 5.  The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies.

Authors:  Cristina Varas-Lorenzo; Andrea V Margulis; Manel Pladevall; Nuria Riera-Guardia; Brian Calingaert; Lorna Hazell; Silvana Romio; Susana Perez-Gutthann
Journal:  BMC Cardiovasc Disord       Date:  2014-09-26       Impact factor: 2.298

6.  Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans.

Authors:  Romina Bertinat; Francisco Nualart; Xuhang Li; Alejandro J Yáñez; Ramón Gomis
Journal:  J Clin Cell Immunol       Date:  2015-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.